Yunnan Baiyao stock reports CNY 10.28 billion in Q2 revenue

Published on 10/07/2026 at 06:37 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Yunnan Baiyao stock posted CNY 1.66386 billion in Q2 net income on August 29, 2026. Revenue fell from CNY 11.60 billion in Q1 to CNY 10.28 billion.

Yunnan Baiyao, CNE0000008X7, Illustration mit AI erstellt.

Yunnan Baiyao (ISIN CNE0000008X7) reported CNY 10.28 billion in second-quarter revenue for 2026, with quarterly net income of CNY 1.66386 billion and earnings per share of CNY 0.93. The results were published on August 29, 2026, and give the pharmaceutical group a fresh operating reference after a special dividend payment in September.

Quarterly revenue falls sequentially

According to Investing.com, Q2 revenue stood at CNY 10.28 billion, compared with CNY 11.60 billion in Q1. The sequential decline makes the CNY 1.66386 billion net income figure more important for assessing how much profitability the business retained as sales moved lower.

The same results page reports Q2 EPS of CNY 0.93 against a forecast of CNY 0.86. That CNY 0.07 difference gives the earnings release a measurable positive comparison, even though quarterly revenue declined from the prior period.

Special dividend adds a cash-return angle

According to MarketScreener on September 16, 2026, Yunnan Baiyao approved a special cash dividend of CNY 1.038 per share, with September 24 as the ex-dividend date. The distribution adds a shareholder-return factor to the earnings picture, while the Q2 figures keep operating performance at the center of the stock story.

The company describes its business around pharmaceuticals, traditional medicine resources, health products and medical distribution. Its investor-relations site also reports 2025 revenue above CNY 41.1 billion, showing the scale of the platform behind the latest quarterly figures.

Analysts see higher value

The consensus on Investing.com is Strong Buy, based on 10 analysts. The average 12-month target is CNY 67.86, with a high estimate of CNY 82.20 and a low estimate of CNY 60.00; the page lists 11 Buy ratings, 1 Hold rating and 0 Sell ratings.

For investors, the contrast is clear: the stock is being judged on earnings quality and cash returns while the quarterly sales comparison remains sequentially negative. The analyst range also shows that the consensus is positive but not uniform in its valuation assumptions.

Yunnan Baiyao stock trades at CNY 50.44

Yunnan Baiyao stock was last at CNY 50.44 on the Shenzhen Stock Exchange on September 30, 2026 at 3:04 p.m. CST, up 0.40 percent on the session. Its 52-week range was CNY 46.29 to CNY 58.20, and its market capitalization was CNY 90.0 billion.